New Team-NB Position Paper Released on IVDR certification process

    New Team-NB Position Paper Released on IVDR certification process

    Regulatory Affairs In Vitro Diagnostics EU IVDR

    Wednesday, 23 April 2025

    person-image

    Kirsten Van Garsse, Authorized Representative Director & Regulatory Affairs Manager IVD

    share-iconshare-icon-mob Share

    X (Twitter) icon\ \ X (Twitter) LinkedIn icon\ \ LinkedIn WhatsApp icon\ \ WhatsApp Copy link icon\ \ Copy link Mail icon\ \ Mail

    On April 14th, 2025, Team-NB, the European Association of Medical Devices Notified Bodies, released a new Position Paper on the certification process under Regulation (EU) 2017/746 (IVDR).

    Play

    New Team-NB Position Paper Released on IVDR certification process | QbD Group

    AI-generated audio

    2:15

    This Position Paper is a Team-NB consensus document describing the pre-application, application and post-application processes through which manufacturers may apply to Notified Bodies for the certification of in vitro medical devices under IVDR.

    What is new?

    The paper was developed in consensus by reviewing the application process and associated documents of individual Team-NB members and harmonising the processes where possible, for the certification of in vitro medical devices (IVDs) under IVDR. The document applies to both legacy IVDs and IVDs that are new to the market. The document also briefly describes the certification activities, undertaken after the application process is concluded.

    The paper gives a detailed overview of notified body expectations and activities during the different phases of certification, being: initial contact & pre-application submission; pre-application review and quotation process; formal application lodging; contract/written agreement and application review; conformity assessment; final review and decision making; certificate issuance; and surveillance activities. Specific, device-type procedures for conformity assessment are included, as well as a brief section on batch verification of class D IVDs. Finally, it includes a list of information/documents to be submitted by the manufacturer during pre-application and formal application.

    What does it mean to you?

    This Team-NB IVDR Certification Process Position Paper is important for all manufacturers of IVDs that require conformity assessment by a notified body. While every notified body may still have some specific requirements and/or expectations, this document provides manufacturers with valuable information on the certification process steps for their products under IVDR, regardless of which notified body they choose.

    CTA RA update

    CTA RA update

    Get in touch with our experts

    Should you want to discuss this more in-depth with one of our consultants, please do not hesitate to contact us.

    Contact us

    Discover more expert content

    Previous

    Regulatory Affairs

    5 Mar 2025

    Call for expression of interest in coordinated assessment of clinical investigations/performance studies

    This pilot will allow sponsors to submit a single application for pilot coordinated assessments,...

    Read more

    Regulatory Affairs

    17 Dec 2025

    Proposal for a Regulation Amending MDR and IVDR

    The proposal introduces wide-ranging changes across the device lifecycle. It focuses on ...

    Read more

    Regulatory Affairs

    23 Apr 2025

    New revision of Team-NB Best Practice Guidance released

    This third revision contains several content updates, examples of common manufacturer’s pitfalls,...

    Read more

    Regulatory Affairs

    23 Apr 2025

    New revision of Team-NB Position Paper on European AI Act

    This Position Paper provides an overview of the Team-NB perspective on the challenges of the AI...

    Read more

    Regulatory Affairs

    17 Nov 2025

    Team-NB publishes two new Position Papers

    On October 22nd Team-NB published two new Position Papers. One addresses changes to companion...

    Read more

    Regulatory Affairs

    5 Mar 2025

    Call for expression of interest in coordinated assessment of clinical investigations/performance studies

    This pilot will allow sponsors to submit a single application for pilot coordinated assessments,...

    Read more

    Regulatory Affairs

    17 Dec 2025

    Proposal for a Regulation Amending MDR and IVDR

    The proposal introduces wide-ranging changes across the device lifecycle. It focuses on ...

    Read more

    Regulatory Affairs

    23 Apr 2025

    New revision of Team-NB Best Practice Guidance released

    This third revision contains several content updates, examples of common manufacturer’s pitfalls,...

    Read more

    Regulatory Affairs

    23 Apr 2025

    New revision of Team-NB Position Paper on European AI Act

    This Position Paper provides an overview of the Team-NB perspective on the challenges of the AI...

    Read more

    Regulatory Affairs

    17 Nov 2025

    Team-NB publishes two new Position Papers

    On October 22nd Team-NB published two new Position Papers. One addresses changes to companion...

    Read more

    Regulatory Affairs

    5 Mar 2025

    Call for expression of interest in coordinated assessment of clinical investigations/performance studies

    This pilot will allow sponsors to submit a single application for pilot coordinated assessments,...

    Read more

    Regulatory Affairs

    17 Dec 2025

    Proposal for a Regulation Amending MDR and IVDR

    The proposal introduces wide-ranging changes across the device lifecycle. It focuses on ...

    Read more

    Next

    • 1
    • 2
    • 3

    Discover all

    Stay ahead in life sciences

    Keeping up with the fast-paced life sciences industry doesn’t have to be overwhelming.

    Our newsletter delivers the latest insights, industry updates, and expert content directly to your inbox, helping you stay informed and make smarter decisions.

    Subscribe to our newsletter

    Circles-banner-short

    Twitter Widget Iframe